• SENSEX 83,432.89
    193.42 (+0.23%)
  • BANKNIFTY 57,031.90
    239.95 (+0.42%)
  • Trent
    5,425.00 4,491.75(%)
  • HDB FINANC SER
    836.00 827.50(%)
  • J B Chemicals &
    1,630.00 1,303.00(%)
  • V-Guard Industri
    401.35 577.35(%)
  • PC Jeweller
    16.83 19.60(%)
  • C P C L
    781.00 1,274.00(%)
  • HDFC Bank
    2,004.25 2,027.40(%)
  • Bajaj Finance
    940.70 978.59(%)
  • Reliance Industr
    1,529.50 1,608.95(%)
  • CreditAcc. Gram.
    1,355.00 1,369.25(%)
  • Petronet LNG
    295.00 269.90(%)
  • Nippon ETF Liq.
    999.99 997.00(%)
  • Cochin Shipyard
    2,073.95 2,977.10(%)
  • Kotak Mah. Bank
    2,136.50 2,301.55(%)
  • TCS
    3,426.00 4,585.90(%)
  • Neetu Yoshi
    110.25 110.25(%)
  • Paras Defence
    933.50 971.80(%)
  • Nuvama Wealth
    7,202.25 4,567.80(%)
  • ICICI Bank
    1,444.00 1,471.10(%)
  • Tata Motors
    686.20 542.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Akums Drugs & Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 34484.0
  • ISIN : INE09XN01023
578.50 -2 (-0.34%)
  • As on 06 Jul 2025 (EOD)

  • Today’s Low

    568.55

  • Today’s High

    583.20

  • Open

    582.00

  • Perv Close

    580.45

  • 52W Low

    405.00

  • 52W High

    1,175.90

Key Indicators

  • P/E(TTM)

    56.48

  • Mar.Cap (₹Cr.)

    9,105.24

  • Div & Yield %

    0.00

  • Book Value(₹)

    146.52

  • Debt-Equity Ratio

    -0.34

  • AGM Date

    04-Jul-2025

  • EPS

    10.23

  • P/E Ratio

    56.48

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    9,105.24

  • RONW (%)

    -2.22

  • ROCE (%)

    1.24

Score Board

  • Equity (₹ in Cr.)

    31.48

  • BV (₹)

    146.50

  • Sales( ₹ in Cr.)

    1,311.78

  • NP (in Cr.)

    161.04

  • NP Var(%)

    202.0

  • Div%

    0.0

  • CPS (₹)

    12.70

  • EPS (₹)

    10.20

  • Traded Value (₹ in Lakhs)

    9,094.22

  • 52 Week High

    1,175.90

  • 52 Week Low

    405.00

  • Price BSE

    578.0

  • Price NSE

    579.00

  • Market Capital( in Cr.)

    9,094.22

  • P/C Ratio

    45.40

  • P/E Ratio

    56.50

  • Price Vs.BV

    10.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,311.78 1,444.12 1,286.83 1,162.06 837.44 736.91
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,311.78 1,444.12 1,286.83 1,162.06 837.44 736.91
Other Income 128.06 94.12 96.15 58.48 54.51 65.52
Stock Adjustments 10.05 -6.44 3.06 18.45 -10.64 -8.52
Total Income 1,449.89 1,531.80 1,386.04 1,238.99 881.31 793.91
EXPENDITURE :            
Raw Materials 811.06 867.24 791.21 786.51 513.05 457.83
Power and Fuel Cost 45.36 42.40 42.04 36.25 28.64 33.74
Employee Cost 201.74 175.28 147.30 136.37 122.65 123.70
Other Manufacturing Expenses 68.18 62.69 42.04 62.62 51.89 24.08
Selling and Administration Expenses 23.27 31.90 22.33 16.82 13.80 12.05
Miscellaneous Expenses 37.60 404.21 147.63 503.99 319.56 37.06
Employee Benefit Expenses 201.74 175.28 147.30 136.37 122.65 123.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,187.20 1,583.73 1,192.54 1,542.55 1,049.59 688.46
Operating Profit 262.69 -51.93 193.50 -303.56 -168.28 105.45
Interest 15.31 18.31 13.18 3.65 0.82 4.34
Gross Profit 247.38 -70.24 180.32 -307.21 -169.10 101.11
Depreciation 39.55 32.69 30.00 27.76 26.10 25.26
Profit Before Tax 207.83 -102.93 150.32 -334.97 -195.20 75.85
Current Tax 46.84 62.52 41.00 0.34 6.40 23.61
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 -16.11 46.46 -56.17 1.38
Reported Net Profit 161.00 -165.45 125.43 -381.78 -145.43 50.86
Extraordinary Items -0.04 -7.98 -105.11 0.99 -255.75 0.02
Adjusted Net Profit 161.04 -157.47 230.54 -382.77 110.32 50.84
Adjustment below Net Profit 861.44 -2.18 0.00 -11.62 0.16 0.00
P & L Balance brought forward 295.39 463.02 351.36 744.75 890.02 839.52
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 13.77 0.00 0.00 0.37
P & L Balance carried down 1,317.83 295.39 463.02 351.36 744.75 890.02
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 10.52 -11.56 8.77 -53.37 -1,117.82 391.04
Earnings Per Share(Adj)-Unit Curr 10.52 - - - - -
Book Value 150.57 10.06 21.77 25.94 4,358.55 5,476.91
Book Value(Adj)-Unit Curr 150.57 - - - - -

Shareholding Pattern

  • Promoter Group

    75.26%

  • Public Share Holding

    22.01%

  • Custodian

    2.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 54,255,380 34.47 54,255,380 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 64,200,000 40.79 64,200,000 1
Others 0 0.00 0 0
Sub Total 118,455,380 75.26 118,455,380 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 9,078,497 5.77 9,078,497 50
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,043,060 0.66 1,043,060 6
Mutual Funds / UTI 9,616,023 6.11 9,616,023 18
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 981,310 0.62 981,310 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 20,718,890 13.16 20,718,890 79
2] Non Institution
Bodies Corporate 871,163 0.55 871,163 197
Clearing Members 77 0.00 77 1
Directors of their Relatives 42 0.00 42 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 110,474 0.07 110,474 381
Foreign Non Institution Other 7,278,535 4.62 7,278,535 1
Hindu Undivided Families 222,815 0.14 222,815 1,534
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 0 0.00 0 0
Individuals holding nominal share capital up to Rs. 1 lakh 5,372,820 3.41 5,372,820 67,137
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 308 0.00 308 1
Others 794 0.00 794 2
Sub Total 13,927,788 8.85 13,927,788 69,282
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 4,291,930 2.73 4,291,930 1
Total Shares held by Custodians and against which Depository Receipts have been issued 4,291,930 2.73 4,291,930 1
Grand Total ( A + B + C ) 157,393,988 100.00 157,393,988 69,366

Company Background

Akums Drugs & Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Akums Drugs & Pharmaceuticals Ltd
  • BSE Code : 34484.0
  • ISIN : INE09XN01023

  • Incorporation Year

    2004

  • Registered Office

    304 Mohan Place LSC Saraswati
    Vihar, Delhi,
    Delhi-110034

  • Telephone

    +91 11 6904 1000

  • FAX

  • Chairman

  • Managing Director

    SANDEEP JAIN

  • Company Secretary

    Dharamvir Malik

  • Auditor

    Walker Chandiok & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Akums Drugs & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Akums Drugs 577.80 1,439.84 1,311.78 56.48 10.70
Abbott India 34,746.45 6,097.18 5,848.91 52.20 44.71
Astrazeneca Phar 9,090.60 1,330.33 1,295.53 196.34 33.26
P & G Health Ltd 5,760.55 1,166.89 1,151.26 38.07 39.76
Glaxosmi. Pharma 3,285.70 3,866.05 3,723.49 60.57 58.72
Cipla 1,513.50 20,029.57 19,044.85 23.70 21.40
Amrutanjan Healt 712.85 437.58 421.23 40.55 20.84
Guj. Themis Bio. 350.45 174.19 169.82 78.23 44.82
Fermenta Biotec. 328.70 315.24 307.09 14.31 4.10
Bliss GVS Pharma 156.00 638.96 605.46 23.82 11.19
Ambalal Sarabhai 36.45 11.70 3.81 33.75 1.92